Literature DB >> 12939424

Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients.

M M Machulda1, H A Ward, B Borowski, J L Gunter, R H Cha, P C O'Brien, R C Petersen, B F Boeve, D Knopman, D F Tang-Wai, R J Ivnik, G E Smith, E G Tangalos, C R Jack.   

Abstract

OBJECTIVE: To determine whether an fMRI memory encoding task distinguishes among cognitively normal elderly individuals, patients with mild cognitive impairment (MCI), and patients with early Alzheimer's disease (AD).
METHODS: Twenty-nine subjects (11 normal, 9 MCI, 9 AD) were studied with an fMRI memory encoding task. A passive sensory task was also performed to assess potential intergroup differences in fMRI responsiveness. Activation in the medial temporal lobe for the memory task and in the anatomic rolandic area for the sensory task was studied. Intergroup comparisons were performed using receiver operating characteristic (ROC) analyses. The ROC method provides rigorous control of artifactual false-positive "activation." Subjects were tested for recall and recognition of the encoding task stimuli following the fMRI study.
RESULTS: Medial temporal lobe activation was greater in normal subjects than MCI and AD patients (p = 0.03 and p = 0.04). There was no difference between AD and MCI patients in fMRI memory performance [corrected]. There was an association between fMRI memory activation (area under the ROC curve) and post-fMRI performance on recognition and free recall. There was no difference among the three groups on the sensory task.
CONCLUSIONS: MCI and AD patients had less medial temporal lobe activation on the memory task than the normal subjects but similar activation as normal subjects on the sensory task. These findings suggest decreased medial temporal activation may be a specific marker of limbic dysfunction due to the neurodegenerative changes of AD. In addition, fMRI is sufficiently sensitive to detect changes in the prodromal, MCI, phase of the disease.

Entities:  

Mesh:

Year:  2003        PMID: 12939424      PMCID: PMC2744465          DOI: 10.1212/01.wnl.0000079052.01016.78

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

1.  Prospective multiaxial motion correction for fMRI.

Authors:  H A Ward; S J Riederer; R C Grimm; R L Ehman; J P Felmlee; C R Jack
Journal:  Magn Reson Med       Date:  2000-03       Impact factor: 4.668

2.  Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers.

Authors:  K R Thulborn; C Martin; J T Voyvodic
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

3.  Functional brain imaging of young, nondemented, and demented older adults.

Authors:  R L Buckner; A Z Snyder; A L Sanders; M E Raichle; J C Morris
Journal:  J Cogn Neurosci       Date:  2000       Impact factor: 3.225

4.  Dissociation of regional activation in mild AD during visual encoding: a functional MRI study.

Authors:  T Kato; D Knopman; H Liu
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

5.  Specificity of brain activation patterns in people at genetic risk for Alzheimer disease.

Authors:  Alison C Burggren; Gary W Small; Fred W Sabb; Susan Y Bookheimer
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

6.  Functional MR imaging in Alzheimer's disease during memory encoding.

Authors:  S A Rombouts; F Barkhof; D J Veltman; W C Machielsen; M P Witter; M A Bierlaagh; R H Lazeron; J Valk; P Scheltens
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

7.  Patterns of brain activation in people at risk for Alzheimer's disease.

Authors:  S Y Bookheimer; M H Strojwas; M S Cohen; A M Saunders; M A Pericak-Vance; J C Mazziotta; G W Small
Journal:  N Engl J Med       Date:  2000-08-17       Impact factor: 91.245

8.  The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and alzheimer disease.

Authors:  S C Johnson; A J Saykin; L C Baxter; L A Flashman; R B Santulli; T W McAllister; A C Mamourian
Journal:  Neuroimage       Date:  2000-03       Impact factor: 6.556

9.  Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R C Petersen; J C Stevens; M Ganguli; E G Tangalos; J L Cummings; S T DeKosky
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

10.  Women at risk for AD show increased parietal activation during a fluency task.

Authors:  C D Smith; A H Andersen; R J Kryscio; F A Schmitt; M S Kindy; L X Blonder; M J Avison
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

View more
  115 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  Potential of functional MRI as a biomarker in early Alzheimer's disease.

Authors:  Reisa Sperling
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

3.  Medial temporal lobe function and structure in mild cognitive impairment.

Authors:  Bradford C Dickerson; David H Salat; Julianna F Bates; Monika Atiya; Ronald J Killiany; Douglas N Greve; Anders M Dale; Chantal E Stern; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

4.  Spontaneous brain activity in mild cognitive impairment revealed by amplitude of low-frequency fluctuation analysis: a resting-state fMRI study.

Authors:  Q Xi; X Zhao; P Wang; Q Guo; H Jiang; X Cao; Y He; C Yan
Journal:  Radiol Med       Date:  2012-01-12       Impact factor: 3.469

5.  Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.

Authors:  Deepti Putcha; Michael Brickhouse; Kelly O'Keefe; Caroline Sullivan; Dorene Rentz; Gad Marshall; Brad Dickerson; Reisa Sperling
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

6.  fMRI responses to words repeated in a congruous semantic context are abnormal in mild Alzheimer's disease.

Authors:  John M Olichney; Jason R Taylor; Shiaohui Chan; Jin-Chen Yang; Andrew Stringfellow; Dieter G Hillert; Amanda L Simmons; David P Salmon; Vicente Iragui-Madoz; Marta Kutas
Journal:  Neuropsychologia       Date:  2010-04-28       Impact factor: 3.139

7.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

8.  Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease.

Authors:  Yakeel T Quiroz; Andrew E Budson; Kim Celone; Adriana Ruiz; Randall Newmark; Gabriel Castrillón; Francisco Lopera; Chantal E Stern
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

9.  Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase.

Authors:  Peter Toth; Stefano Tarantini; Zsuzsanna Tucsek; Nicole M Ashpole; Danuta Sosnowska; Tripti Gautam; Praveen Ballabh; Akos Koller; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

Review 10.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.